A B S T R A C T Multiple myeloma is a malignancy characterized by uncontrolled monoclonal B cell differentiation and immunoglobulin production. In most instances, there is concomitant reduction in polyclonal differentiation and immunoglobulin synthesis both in vivo and in vitro. In in vitro pokeweed mitogen-induced B cell differentiation assays, proliferation and polyclonal immunoglobulin secretion optimally requires T cell help and can be inhibited both by monocytes and suppressor T cells. Helper function and monocyte-mediated suppression are relatively radioresistant whereas T suppressor function is sensitive to 2,000 rad x-irradiation. We have examined myeloma T cell subset function in this assay using recombinations of isolated patient and normal B cells, T cells, and T cell subsets. Monocytes were removed by a carbonyl iron ingestion technique, normal and myeloma T cells were fractionated on the basis of Fc receptors for immunoglobulin (Ig)G (Ty) or IgM (T,u or T non-y), and proliferation and IgG secretion after co-culture determined by [3H]thymidine incorporation and radioimmunoassay, respectively. Myeloma B cells demonstrate quantitatively and qualitatively normal blastogenic responses and are appropriately regulated by either autologous or allogeneic T helper and suppressor subsets. Despite normal proliferation, however, myeloma B cells remain deficient in subsequent differentiation and immunoglobulin secretion even when co-cultured in the absence of monocytes or suppressor T cells and the presence ofnormal helper cells. Myeloma T cell populations, in contrast, are entirely normal in helper capacity over a range of T:B ratios but are markedly deficient in radiosensitive and concanavalin A-induced suppressor activity. T suppressor cell dysfunction in multiple myeloma is apparently due to a deficit in the T non-y suppressor subset, whereas Ty cells, although proportionately reduced, are functionally normal. This unique T suppressor deficit reflects the heterogeneity of suppressor mechanisms in this disease and may represent a compensatory
A B S T R A C T Multiple myeloma is a malignancy characterized by uncontrolled monoclonal B cell differentiation and immunoglobulin production. In most instances, there is concomitant reduction in polyclonal differentiation and immunoglobulin synthesis both in vivo and in vitro. In in vitro pokeweed mitogen-induced B cell differentiation assays, proliferation and polyclonal immunoglobulin secretion optimally requires T cell help and can be inhibited both by monocytes and suppressor T cells. Helper function and monocyte-mediated suppression are relatively radioresistant whereas T suppressor function is sensitive to 2,000 rad x-irradiation. We have examined myeloma T cell subset function in this assay using recombinations of isolated patient and normal B cells, T cells, and T cell subsets. Monocytes were removed by a carbonyl iron ingestion technique, normal and myeloma T cells were fractionated on the basis of Fc receptors for immunoglobulin (Ig)G (Ty) or IgM (T,u or T non-y), and proliferation and IgG secretion after co-culture determined by [3H]thymidine incorporation and radioimmunoassay, respectively. Myeloma B cells demonstrate quantitatively and qualitatively normal blastogenic responses and are appropriately regulated by either autologous or allogeneic T helper and suppressor subsets. Despite normal proliferation, however, myeloma B cells remain deficient in subsequent differentiation and immunoglobulin secretion even when co-cultured in the absence of monocytes or suppressor T cells and the presence ofnormal helper cells. Myeloma T cell populations, in contrast, are entirely normal in helper capacity over a range of T:B ratios but are markedly deficient in radiosensitive and concanavalin A-induced suppressor activity. T suppressor cell dysfunction in multiple myeloma is apparently due to a deficit in the T non-y suppressor subset, whereas Ty cells, although proportionately reduced, are functionally normal. This unique T suppressor deficit reflects the heterogeneity of suppressor mechanisms in this disease and may represent a compensatory INTRODUCTION Multiple myeloma (MM)' is clinically defined as a malignant plasma cell proliferation resulting in bone marrow replacement, paraprotein production, osteolytic bone lesions, decreased polyclonal immunoglobulin (Ig) synthesis, and a concomitant increase in susceptibility to certain bacterial pathogens (1) (2) (3) . The immunodeficiency of myeloma is distinct from that of other malignancies in that both myeloma patients and mice bearing plasmacytomas exhibit impaired primary responses to antigenic challenge, whereas secondary responses as well as delayed hypersensitivity are less severely affected (1, (3) (4) (5) (6) (7) . A variety of hypotheses have been suggested to explain impaired host polyclonal Ig synthesis in both multiple myeloma and murine plasmacytomas including the alteration of antigenbinding cells by infective RNA subunits from malignant plasma cells (8) , the influence of mitotic inhibitors or chalones that block polyclonal B cell differentiation (9) , and the presence ofcirculating immunosuppressive factors produced by murine plasmacytoma cells (10) . In contrast to studies attributing the depressed primary responses and Ig levels to an immunosuppressive product of the expanding population of tumor cells, Broder et al. (11) originally suggested that a potential abnormality of host immunoregulatory cells might be involved in the immunodeficiency of myeloma in man (11) . They demonstrated suppressor activity by unfractionated myeloma peripheral leukocytes that was mediated primarily by phagocytic mononuclear cells and not by T lymphocytes. Similar adherent cell suppressor mechanisms have been demonstrated in the murine plasmacytoma model (5, 12) and in addition an augmenting role for tumor cell factors on macrophage-mediated suppression has been suggested. Knapp T helper activity in these patients in nonetheless functionally intact over a range of T:B ratios, and (c) unlike the leukemic cell population in most patients with chronic lymphocytic leukemia, the early stage of peripheral B cell differentiation in MM, T cellregulated B cell proliferation, is virtually normal, whereas (d) a specific T suppressor abnormality can be identified in these patients for T cell-regulated IgG secretion. The suppressor deficit in multiple myeloma is further shown to be confined to the T non-y suppressor cell subset that demonstrated sensitivity to 2,000 rad x-irradiation and is inducible in the presence of concanavalin A.
METHODS
Patient population. 23 different healthy volunteer agematched donors who were receiving no medication were used as controls. A total of 21 different patients with MM between 48 and 63 yr of age were included in this study. The diagnosis of multiple myeloma was confirmed by the presence of at least two of the following criteria: (a) plasma cells constituting >20% of the total nucleated cell population of aspirated bone marrow without other known causes; (b) a monoclonal serum or urine gamma globulin peak on immunoelectrophoresis in combination with reduction in other serum Ig, and (c) osteolytic lesions in the skull, vertebral column, or pelvis. Of the 21 patients examined, 14 had not received prior therapy and were newly diagnosed. The remaining seven patients had previously received intermittent therapy with alkylating agents and corticosteroids, however these patients were sampled at least 6-8 wk following completion of their last drug cycle or were off chemotherapy altogether. 18 of the myeloma patients examined had IgG components and three had IgA; none had macroglobulinemia or light chain diseases.
Isolation of lymphocyte populations. Peripheral leukocyte populations were obtained from buffy coats separated either by leukopheresis ofboth patients and normal volunteers with a Haemonetics model 30 Cell Separator (Haemonetics Corp., Natick, Mass.) or by gravity sedimentation of 500 ml of citrated blood from some volunteer donors. No differences in surface markers or in vitro functional capacity of lymphocytes obtained by either method were apparent in our assays. Informed consent was routinely required before patients were entered into this study. Phagocytic mononuclear cells were depleted by diluting each buffy coat 1:2 with medium containing carbonyl iron (Technicon Instrument Co., Tarrytown, N. Y.) in 50-ml aliquots, and incubating the mixture for 60 min with gentle continuous agitation. Each leukocyte population was then layered in 10-ml aliquots on 3 ml FicollHypaque density gradients (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.), in 15-ml siliconized glass tubes and centrifuged 40 min at 400 g. The interface layer was resuspended in RPMI 1640 (Gibco Laboratories, Grand Island Biological Co., Grand Island, N. Y.) and washed two times. Viability ofthe purified lymphocyte populations was routinely >95% and monocyte contamination was always <2% by nonspecific esterase staining and latex bead ingestion.
E rosette positive (E+) and negative (E-) lymphocyte populations were obtained by rosetting with sheep erythrocytes (SRBC) that had been treated with 2-aminoethylisothiouronium bromide according to the method of Kaplan and Clark (16 Co-culture methods. IgG produced by isolated subpopulations and in co-culture experiments was determined by a modification of the technique described by Gailani et al. (20) . Lymphocyte populations were adjusted to a final concentration of2 x 106 cells per ml in RPMI 1640 supplemented with glutamine, 0.1 ng/ml gentamicin and previously screened, heat-inactivated 10% FCS. The cell suspensions were incubated in flat-bottomed microtiter plates (Linbro Chemical Co., Hamden, Conn.) for 7 d at 370C in a humidified 5% CO2 atmosphere. In co-culture experiments, ratios of B:T cells were maintained at 1:2 while T cell subpopulations were recombined in equal ratios unless otherwise noted such as in the titration experiments. The total well volume was 350 gl.
In some experiments, T cells were irradiated with 2,000 rad x-irradiation fromii a General Electric Maxitron 250 x-ray machine (General Electric Co., Schenectady, N. Y.) using 0.25-mm Cu and 1-mm Al filters. Proliferation responses were determined on day 3 of culture following a 6-h pulse with 2 ,tCi/well of tritiated thymidine (TdR) (sp act 6.7 Ci/ mmol) and subsequent harvesting ofthe entire contents ofthe well for liquid scintillation counting. Radioimmunoassay was performed on day 7 by a double antibody technique using 200 ,l. of supemate from each well following centrifugation of the plate. Affinity-column purified human IgG, previously shown to be specific by gel double diffusion and immunoelectrophoresis, was labeled with 1 mCi of 125I using a chloramine-T method. The dilution of anti-IgG that bound 60% of a suitable amount of labeled IgG was determined. Anti-IgG was prepared by multiple rabbit immunizations with purified IgG protein followed by affinity column purification of the antibody. Antigen-antibody dilution curves were constructed for an antigen range of 1 to 30 ng and a 1:8,000 dilution of antiserum. The amount of goat anti-rabbit Ig added to precipitate the rabbit Ig was twice the equivalence amount. After overnight incubation at 4°C, 1.0 ml of 0.01 M Tris, pH 7.0-7.4, was added to each tube. The tubes were centrifuged at 4°C and 2,000 g for 20 min, after which the supemate was discarded, and the pellet counted. Standards were prepared in 0.01 M Tris with 1% bovine serum albumin. The IgG Secretion by B + Tx + cultured T where B + Tx co-cultures were performed using normal autologous cell populations and allogeneic cultured T cells as controls. T Con A cells consisted of allogeneic normal or patient T cells and subsets incubated 48 h with Con A. Total cocultures contained 1 x 105 cells of each subpopulation.
Statistical analysis. Data are presented as either ranges or means± SEM ofthe total patient and normal donor populations for both [3H]thymidine incorporation and IgG production. Individual experiments were performed with paired patient and normal samples in triplicate in each instance, and the individual means were used to calculate the group means as presented. The statistical significance of the difference between mean values in the various groups was determined by the student's t test and for individual pairs by the paired t test. A P value of <0.05 was considered to represent a significant result and is so indicated in the figures and tables.
RESULTS
Surface markers of lymphocyte subsets. Myeloma lymphocyte populations were readily separable into E+ and E-populations with at least 95% purity in every instance by repeat surface marker analysis (Table I) . The E-population was greatly enriched for slgbearing cells and cells bearing complement receptors. In both patients and normal individuals, an average of 70% of this population is identifiable as B lymphocytes by the presence of sIg. The remainder of the Epopulation from normal donors consists of a very small proportion of contaminating E+ T cells (3-5%) and a null population which is heterogeneous for Ia, complement and Fc receptors, but highly active in two in vitro assays: antibody-dependent cellular cytotoxicity and natural killing (18, 21) . yFcR+ and ,uFcR+ subsets of T lymphocytes could also be easily identified and the Ty fraction readily separated from both myeloma and normal T lymphocyte populations. The proportions of total T cells bearing receptors for either IgG or IgM were equally variable in patients and normal individuals and -90-95% of the total T population was found to bear Fc receptors for one or the other class of Ig. Repeat Fc-rosetting following positive selection demonstrated enrichment to at least 65-90% of cells bearing the Fc receptor specifically isolated, whereas <3% of either subset bore the nonselected Fc receptor. Thus both the Ty and T,u subset could be isolated with >95% purity by negative criteria although masking of the receptors during the separation apparently prevents repeat rosetting of a proportion of T Cell Function in Myeloma T cell-regulated IgG production by normal and myeloma B cells. The in vitro production of IgG by isolated normal and myeloma lymphocyte populations after pokeweed mitogen (PWM) stimulation was determined in the absence of monocytes (<2%) for 14 normal donors and 13 myeloma patients. IgG secretion after a 7-d incubation period is expressed as nanograms IgG per milliliter, which was equivalent in our culture system to nanograms/3 x 105 total lymphocytes or nanograms per liter x 105 B cells cultured (Table II) .
Isolated T and B populations from normal donors and patients produced only minimal amounts of IgG while co-culture of normal T and B populations produced -1,300 ng/ml. In contrast, inonocyte-depleted myeloma T and B co-cultures were significantly depressed (P < 0.005) in their ability to produce IgG. In an initial attempt to determine the role of myeloma T cell regulation of polyclonal Ig synthesis, we cultured autologous B and T cells after prior x-irradiation of the total T populations. Moderate doses (1-2,000 rad) xirradiatioin have been previously demonstrated to selectively abrogate polyclonal suppressor T cell function in a similar assay system (22) , while adherent suppressor cells are relatively more radioresistant (13) . Fig. 1 , there are significant increases in IgG production with prior T cell x-irradiation whether the differentiating B cell population is autologous or allogeneic. In order to exclude the possibility that a more subtle deficiency in T helper activity might be involved in MM, we also examined T cell help for Ig secretion using serial dilutions ofnormal and patient T cells co-cultured with a constant 1 x 105 normal B cells. In the three separate patients and normal controls shown in Fig. 2 , no significant difference in helper function could be identified even at T:B ratios of0.1. The radiation-induced increment in IgG secretion was evident only for normal donor T populations at T:B ratios of 0.5 or greater and was nonexistent in these three myeloma patients. Thus, although myeloma T cells are relatively normal in helper function, we were unable to demonstrate the expected radiosensitive suppressor activity by total myeloma T lymphocyte populations.
Immunoregulatory capacity ofnormal and myeloma T cell subsets on autologous B cell function. This Although a low to moderate dose (2,000 rad) xirradiation of the T non-y subset resulted in a decrease in total thymidine incorporation for B and T cocultures, a radioresistant increment in helper activity for Ig secretion was demonstrable for this subset from the presence of the myeloma T non-y subset and this suppressor activity is radiosensitive to 2,000 rad. A marked distinction between myeloma and normal T helper function is demonstrated, however, by irradiation of the T non-y population. As previously described for total myeloma T cell populations, x-irradiation of the T non-y subset also fails to produce the normal increment in IgG secretion and, in these four patients, resulted in a small decrease in mean IgG production. The results presented here argue strongly against an abnormality of either Ty suppressor activity or T non-y helper function in MM. Both T non-y helper and Ty suppressor function were intact in untreated patients despite the inability of autologous patient E-cells (which contained FcR+ null cells as well as sIg+ cells) to differentiate into plasma cells. In an effort to examine myeloma suppressor function by a parameter independent of Ty subset interaction with antigenantibody complexes, we have also used the functional sensitivity of T suppressor activity to low-dose x-irradiation and Con A-induction of suppressor activity. Radioresistance of T cell help and sensitivity of T suppressor function to low doses of x-irradiation has been described for total T cells (22) as well as fractionated Ty cells (19) . The failure of the irradiated patient total T population to demonstrate the expected increment in help suggested either a functional or proportional Ty deficit in MM. In the experiments described here, the T non-y subset from normal donors demonstrated an x-ray induced increment in IgG secretion equal to total irradiated T cells. Although this might possibly be explained by a failure to totally deplete T cells with IgG receptors, it seems highly improbable that the 2-3% of contaminating Ty cells detected after separation could account for the observed 50% increment in helper activity following irradiation or for Con A-inducible suppressor activity within the T non-y subset. The presence of radiosensitive suppressor cells in the T non-y fraction has been previously described (26) and although both the Ty and T non-y subsets contain suppressor activity, the Con A-inducible T suppressor cell defined phenotypically with monoclonal antibodies lacks Fc receptors for IgG (24) .
It appears more likely, therefore, that help and suppresssion cannot be ascribed to mutually exclusive T cell subsets based on the cellular expression of a particular class of Fc receptor. Pichler et al. (27) have previously demonstrated the modulation of Ty to T,u cells following interaction with immune complexes and suggested that expression of a given receptor might reflect an activational state rather than a unique functional subset analogous to murine T cell subsets defined by alloantisera (28, 29) . Our data are consistent with this hypothesis and provide evidence that human T suppressor cells are indeed heterogeneous with respect to surface Fc receptors for IgG and IgM. Sensitivity to both low-dose irradiation and to corticosteroids in vitro appears to be a more uniform characteristic of human suppressor T cells in B cell differentiation assays than does the presence of receptors for IgG (22, 30, 31) suggesting the necessity for DNA synthesis as a prerequisite to suppressor function by at least some T cell subsets. Similar results have been obtained in murine T suppressor experiments (32) although this conclusion remains controversial, perhaps because of the wide variety of assays used in measuring suppression. Our finding that total myeloma T populations as well as the MM T non-y subset fail to demonstrate an x-ray induced increment in help or Con A-inducible suppressor activity supports the conclusion that the normal T non-y subpopulation contains prosuppressor T cells that are functionally de- (21, 23, 24, 33) although its suppressor sensitivity to 2,000 rad x-irradiation makes it functionally more analogous to Con A-inducible T nony and Ty suppressors than to adherent cells capable of suppressing B cell differentiation in a similar assay system (13) . The explanation for abnormalities of suppressor cell function in MM also remains elusive. The T suppressor dysfunction demonstrated here may represent a normal compensation of the regulatory network in response to increased activity by non-T suppressor populations or, alternatively, the immunopathology of multiple myeloma may actually involve regulatory T cell subsets.
